Zdrowie i gospodarka · 15/09/2000

FDA Extends Nomination Period for Nonvoting Members of Industry Interests on Public Advisory Committees

The Food and Drug Administration (FDA) is extending the nomination period for nonvoting representatives of industry interests to serve on public advisory committees under the FDA's Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER), originally announced in the Federal Register on August 16, 2000.